Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Godin Gilbert
 2. Date of Event Requiring Statement (Month/Day/Year)
01/01/2010		 3. Issuer Name and Ticker or Trading Symbol
BIOVAIL CORP INTERNATIONAL [BVF]
(Last)
(First)
(Middle)
C/O BIOVAIL CORPORATION,, 7150 MISSISSAUGA ROAD		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Executive Vice-President & COO
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

MISSISSAUGA, A6 L5N 8M5		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock, no par value 9,000
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (right to purchase)   (1) 05/23/2011 Common Stock, no par value 100,000 $ 25.78 D  
Stock Options (right to purchase)   (2) 03/22/2012 Common Stock, no par value 100,000 $ 22.05 D  
Restricted Share Units 03/12/2011 03/12/2011 Common Stock, no par value 7,491 (3) $ (4) D  
Stock Options (right to purchase)   (5) 04/01/2013 Common Stock, no par value 75,000 $ 10.83 D  
Restricted Share Units 02/25/2012 02/25/2012 Common Stock, no par value 7,867 (6) $ (4) D  
Stock Options (right to purchase)   (7) 03/09/2014 Common Stock, no par value 90,000 $ 10.86 D  
Restricted Share Units 08/05/2014 08/05/2014 Common Stock, no par value 75,459 (8) $ (4) D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Godin Gilbert
C/O BIOVAIL CORPORATION,
7150 MISSISSAUGA ROAD
MISSISSAUGA, A6 L5N 8M5		       Executive Vice-President & COO  

Signatures

/s/ Angie Palmer, by Power of Attorney 01/04/2010
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) On May 23, 2006, the Reporting Person was granted 100,000 Stock Options. 25,000 Stock Options vested and became exercisable on each of May 23, 2007, 2008 and 2009. The remaining 25,000 Stock Options will vest and become exercisable on May 23, 2010.
(2) On March 22, 2007, the Reporting Person was granted 100,000 Stock Options. 25,000 Stock Options were exercisable as of the grant date and 25,000 Stock Options vested and became exercisable on each of March 1, 2008 and 2009. The remaining 25,000 Stock Options will vest and become exercisable on March 1, 2010.
(3) Includes an initial grant of 6,250 Restricted Share Units (granted on March 12, 2008) and additional Restricted Share Units that were allocated to the Reporting Person as dividend equivalents on the payment date(s) of dividends on Common Stock, no par value, of Biovail Corporation (the "Common Stock").
(4) Each Restricted Share Unit represents a contigent right to receive one share of Common Stock.
(5) On April 1, 2008, the Reporting Person was granted 75,000 Stock Options. 25,000 Stock Options vested and became exercisable on April 1, 2009 and 25,000 Stock Options will vest and become exercisable on each of April 1, 2010 and 2011.
(6) Includes an initial grant of 7,500 Restricted Share Units (granted on February 25, 2009) and additional Restricted Share Units that were allocated to the Reporting Person as dividend equivalents on the payment date(s) of dividends on Common Stock.
(7) On March 9, 2009, the Reporting Person was granted 90,000 Stock Options which will vest and become exercisable in three equal annual installments commencing on the first anniversary of the grant date.
(8) Includes an initial grant of 75,000 performance based Restricted Share Units (granted on August 5, 2009) and additional Restricted Share Units that were allocated to the Reporting Person as dividend equivalents on the payment date(s) of dividends on Common Stock.
 
Remarks:
See Exhibit 24.1 - Power of Attorney

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.